相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of RAF/MEK/ERK Pathway, p-STAT-3 and Mcl-1 in Sorafenib Activity in Human Pancreatic Cancer Cell Lines
Paola Ulivi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
Elizabeth Poplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
David Cunningham et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment
Philip A. Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Biologic therapies for advanced pancreatic cancer
Aiwu Ruth He et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
Shin Nakahira et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines
Woo Sun Kwon et al.
PHARMACOGENETICS AND GENOMICS (2006)
Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer
LL Siu et al.
CLINICAL CANCER RESEARCH (2006)
A common polymorphism in the 3′UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population
Z Hu et al.
LUNG CANCER (2005)
Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance
G Bepler et al.
LUNG CANCER (2005)
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
R Rosell et al.
CLINICAL CANCER RESEARCH (2004)
Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma
W Szczeklik et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer
R Rosell et al.
ONCOGENE (2003)
Common promoter variant in cyclooxygenase-2 represses gene expression - Evidence of role in acute-phase inflammatory response
A Papafili et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
分享论文
